65 results on '"Banales, Jesus Maria"'
Search Results
2. WED-271 Circulating vesicle microRNAs for metabolic dysfunction-associated steatotic liver disease (MASLD) staging and progression towards liver cancer
3. THU-210 Dysfunctional activation of the DNA damage response is associated with MASLD progression through an E2F2-dependent mechanism
4. OS-076-YI Bile extracellular vesicles hold protein biomarkers for the early diagnosis of cholangiocarcinoma in individuals with primary sclerosing cholangitis
5. WED-558 Inhibition of miR-21 improves muscle activity in experimental metabolic dysfunction-associated steatotic liver disease
6. OS-101-YI Remodelling of hepatocyte cholesterol metabolism mediates colorectal liver metastasis
7. The E2F2-miR34a-5p axis is involved in the biliary metabolism dysregulation in NASH
8. Therapeutic potential of targeting protein hyper-SUMOylation in cholangiocarcinoma
9. Novel platinum-based chemotherapeutic agents halt cholangiocarcinoma progression through the induction of inter-strand DNA breaks, preventing DNA repair mechanisms
10. Liquid biopsy protein biomarkers of cholangiocarcinoma risk, early diagnosis and survival mirroring tumor cells
11. Scavenger receptor MARCO is associated with an immunosuppressive microenvironment and tumor progression in intrahepatic cholangiocarcinoma
12. A3907, a systemic ASBT inhibitor, improves cholestasis in mice by inhibiting multi-organ bile acid transport and shows translational relevance to human
13. Targeting the E2F/MCM axis in cholangiocarcinoma halts disease progression in experimental models by rewiring lipid metabolism
14. Validation of serum biomarker panels for early HCC detection: results from a large prospective European and Latin American multicenter study
15. E2F2-promoted DNA damage in NASH worsens the metabolic scenario
16. Silencing CNNM4 in cholangiocarcinoma inhibits tumoral progression by means of non-canonical ferroptosis
17. Functional and mechanistic role of lncRNA-C1 in cholestatic liver diseases
18. KLF5 upregulation is a common event in cholangiocarcinoma, acting as an oncogene and constituting a bad prognostic factor
19. Role of TGR5 in fat-to-liver communication during NAFLD
20. Role of GATA4 in the modulation of hepatic progenitor cell fate
21. Circulating vesicles hold etiology-related protein biomarkers of cholangiocarcinoma risk, early diagnosis and prognosis mirroring tumour cells
22. The uptake of extracellular lipids promotes cholangiocarcinoma progression
23. Presence of cirrhosis in chronic liver disease patients associates with a lower immune response to COVID-19 vaccines-a multicenter european study
24. Proteomic analysis of bile in the rat thioacetamide model reveals new mechanisms in human cholangiocarcinogenesis
25. Cholangiocarcinoma landscape in Europe: diagnostic, prognostic and therapeutic insights from the ENSCCA Registry
26. Methionine adenosyltransferase 1a antisense oligonucleotides induce the fibroblast growth factor 21-driven recovery from obesity and associated hepatoesteatosis
27. The metabolic dysfunction-associated fatty liver disease definition, regardless of its clinical subclassification, identifies patients at high risk for liver disease progression
28. The DNA damage response is involved in the metabolic dysregulation of MAFLD patients via inefficient fatty acid oxidation
29. Metabolic dysfunction-associated fatty liver disease increases cardiovascular risk regardless of classical risk factors
30. Reduced hepatic expression of PPAR alpha in primary biliary cirrhosis is modulated by miR-155
31. Targeting NAE1-mediated protein hyper-NEDDylation halts cholangiocarcinogenesis and impacts on tumour-stroma crosstalk in experimental models
32. Metabolic NAFLD subtypes align with cardiovascular and genetic risk factors
33. SAT-159-YI Mitochondrial integrity and auto (mito)phagy are disrupted in experimental models of primary biliary cholangitis, contributing to disease pathogenesis
34. WED-408 - E2F2-promoted DNA damage in NASH worsens the metabolic scenario
35. WED-404 - The E2F2-miR34a-5p axis is involved in the biliary metabolism dysregulation in NASH
36. WED-397 - Role of TGR5 in fat-to-liver communication during NAFLD
37. SAT-244 - Silencing CNNM4 in cholangiocarcinoma inhibits tumoral progression by means of non-canonical ferroptosis
38. SAT-238 - Liquid biopsy protein biomarkers of cholangiocarcinoma risk, early diagnosis and survival mirroring tumor cells
39. SAT-223 - Therapeutic potential of targeting protein hyper-SUMOylation in cholangiocarcinoma
40. SAT-226 - KLF5 upregulation is a common event in cholangiocarcinoma, acting as an oncogene and constituting a bad prognostic factor
41. SAT-215 - Targeting the E2F/MCM axis in cholangiocarcinoma halts disease progression in experimental models by rewiring lipid metabolism
42. SAT-212 - Novel platinum-based chemotherapeutic agents halt cholangiocarcinoma progression through the induction of inter-strand DNA breaks, preventing DNA repair mechanisms
43. FRI-282 - Validation of serum biomarker panels for early HCC detection: results from a large prospective European and Latin American multicenter study
44. SAT-367 - Role of GATA4 in the modulation of hepatic progenitor cell fate
45. WED-223 - Functional and mechanistic role of lncRNA-C1 in cholestatic liver diseases
46. OS-074-YI - A3907, a systemic ASBT inhibitor, improves cholestasis in mice by inhibiting multi-organ bile acid transport and shows translational relevance to human
47. OS-024-YI - Scavenger receptor MARCO is associated with an immunosuppressive microenvironment and tumor progression in intrahepatic cholangiocarcinoma
48. TREM-2 defends the liver against hepatocellular carcinoma through multifactorial protective mechanisms
49. 159 - KLF5 UPREGULATION IS A COMMON EVENT IN CHOLANGIOCARCINOMA, ACTING AS AN ONCOGENE AND CONSTITUTING A BAD PROGNOSTIC FACTOR
50. TREM-2 defends the liver against hepatocellular carcinoma through multifactorial protective mechanisms
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.